FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alan Feingold

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Evoked Potentials, Auditory

Activities & Behaviors

Smoking Cessation

Co-author Network

Publications

TOP 3
Nashaat N Boutros; Oleg Korzyuko; Glen Oliwa; Alan Feingold; Duane Campbell; Dennis McClain-Furmanski; Frederick A Struve; Ben H Jansen
Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report.
Nashaat N Boutros; Oleg Korzyukov; Ben Jansen; Alan Feingold; Morris Bell
Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients.
Thomas Kosten; Jean Falcioni; Alison Oliveto; Alan Feingold
Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alan Feingold (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Nashaat N Boutros; Oleg Korzyuko; Glen Oliwa; Alan Feingold; Duane Campbell; Dennis McClain-Furmanski; Frederick A Struve; Ben H Jansen
Morphological and latency abnormalities of the mid-latency auditory evoked responses in schizophrenia: a preliminary report.
Schizophrenia research 2004;70(2-3):303-13.
2004: Nashaat N Boutros; Oleg Korzyukov; Ben Jansen; Alan Feingold; Morris Bell
Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients.
Psychiatry research 2004;126(3):203-15.
2004: Thomas Kosten; Jean Falcioni; Alison Oliveto; Alan Feingold
Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2004;13(2):191-201.
2003: Gerardo Gonzalez; Alan Feingold; Alison Oliveto; Kishor Gonsai; Thomas R Kosten
Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management.
The American journal of drug and alcohol abuse 2003;29(3):497-514.
2003: Alison Oliveto; Thania Benios; Kishor Gonsai; Alan Feingold; James Poling; Thomas R Kosten
D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure.
Experimental and clinical psychopharmacology 2003;11(3):237-46.
2003: Thomas Kosten; Alison Oliveto; Alan Feingold; James Poling; Kevin A Sevarino; Elinore F McCance-Katz; Susan Marie Stine; Gerardo Gonzalez; Kishor Gonsai
Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
Drug and alcohol dependence 2003;70(3):315-25.
2003: Alison Oliveto; Kevin A Sevarino; Elinore F McCance-Katz; T Benios; James Poling; Alan Feingold
Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure.
Behavioural pharmacology 2003;14(2):97-109.
2002: Nashaat N Boutros; Ralitza Gueorguieva; Ralph E Hoffman; Dan A Oren; Alan Feingold; Robert M Berman
Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression.
Psychiatry research 2002;113(3):245-54.
2002: Tony P George; Jennifer C Vessicchio; Angelo Termine; Thomas A Bregartner; Alan Feingold; Bruce J Rounsaville; Thomas R Kosten
A placebo controlled trial of bupropion for smoking cessation in schizophrenia.
Biological psychiatry 2002;52(1):53-61.
2002: Thomas R Kosten; Alison Oliveto; Kevin A Sevarino; Kishor Gonsai; Alan Feingold
Ketoconazole increases cocaine and opioid use in methadone maintained patients.
Drug and alcohol dependence 2002;66(2):173-80.
2002: Alan Feingold; Alison Oliveto; Richard S Schottenfeld; Thomas R Kosten
Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers.
The American journal on addictions / American Academy of Psychiatrists in Alcoholism and Addictions 2002;11(2):111-23.
2002: Alison Oliveto; Kevin A Sevarino; Elinore F McCance-Katz; Alan Feingold
Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure.
Pharmacology, biochemistry, and behavior 2002;71(1-2):85-96.
2000: Tony P George; DM Ziedonis; Alan Feingold; W T Pepper; C A Satterburg; Justin D Winkel; Bruce J Rounsaville; Thomas R Kosten
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia.
The American journal of psychiatry 2000;157(11):1835-42.
1999: Alison Oliveto; Alan Feingold; Richard S Schottenfeld; Peter Jatlow; Thomas R Kosten
Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
Archives of general psychiatry 1999;56(9):812-20.